SCHEMBL7204474

SCHEMBL7204474

CN(C)[C@@H]1CCc2c([nH]c3ccc(NC(=O)c4ccc(F)cc4)cc23)C1

nearest known ligand 0.87

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HTR1F P30939 3/20 0.87
HTR1D P28221 10/20 0.47
HTR1B P28222 7/20 0.47
HTR1A P08908 1/20 0.47
MAPT P10636 1/20 0.46
MCHR1 Q99705 1/20 0.45
CHRM2 P08172 1/20 0.44
DRD2 P14416 1/20 0.44
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
ESR1 P03372 1/20 0.43
MAPKAPK2 P49137 1/20 0.43
STK17B O94768 1/20 0.43
STK17A Q9UEE5 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7655540 1.00 HTR1F (0.87) HTR1FHTR1DHTR1BHTR1AMAPT
SCHEMBL8110900 0.93 HTR1F (1.00) HTR1FHTR1DHTR1BHTR1AMAPT
SCHEMBL7665368 0.93 HTR1F (1.00) HTR1FHTR1DHTR1BHTR1AMAPT
Hydrochloric Acid SCHEMBL30819314 0.92 HTR1F (0.98) HTR1FHTR1DHTR1BHTR1AMAPT
SCHEMBL7664552 0.85 HTR1F (0.85) HTR1FHTR1DHTR1BHTR1AMAPT
SCHEMBL7656271 0.84 HTR1F (0.84) HTR1FHTR1DHTR1BHTR1AMAPT
SCHEMBL7658586 0.84 HTR1F (0.83) HTR1FHTR1DHTR1BHTR1AMAPT
SCHEMBL7665351 0.84 HTR1F (0.83) HTR1FHTR1DHTR1BHTR1AMAPT
SCHEMBL7660809 0.83 HTR1F (0.82) HTR1FHTR1DHTR1BHTR1AMAPT
SCHEMBL7655276 0.83 HTR1F (0.82) HTR1FHTR1DHTR1BHTR1AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030004207-A1 USE OF COMPOUNDS WHICH ACTIVATE A 5-HT RECEPTOR TO TREAT URINARY INCONTINENCE SYNAPTIC PHARMACEUTICALS CORPORATION 2003-01-02 US disclosed
US-6380201-B1 Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F agonists ELI LILLY AND COMPANY 2002-04-30 US disclosed
US-5962473-A Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F ELI LILLY AND COMPANY (US) 1999-10-05 US disclosed
US-5814653-A SUMATRIPTAN FOR RELIEF OF MIGRAINE PAIN AND OTHER DISORDERS ASSOCIATED WITH PEPTIDE EXTRAVASATION DIE TO STUMULATION OF THE TRIGEMINAL GANGLIA; 5-HT 1F AGONISTS ELI LILLY AND COMPANY (US) 1998-09-29 US disclosed
EP-0832650-A2 Use of serotonin 5-HT1F agonists for the prevention of migraine ELI LILLY AND COMPANY (US) 1998-04-01 EP disclosed
EP-0824917-A2 Use of a serotonin 5-HTlf agonist in the manufacture of a medicament for treating or ameliorating the symptoms of common cold or allergic rhinitis ELI LILLY AND COMPANY (US) 1998-02-25 EP disclosed
US-5708187-A MIGRANE HEADACHES ELI LILLY AND COMPANY (US) 1998-01-13 US disclosed
EP-0749962-A1 6-substituted-1,2,3,4-tetrahydro-9H-carbazoles and 7-substituted-10H-cyclohepta(7,6-B)indoles ELI LILLY AND COMPANY (US) 1996-12-27 EP disclosed